MULTIMODAL NEUROIMAGING IN THE DIAGNOSIS AND TREATMENT STRATEGY SELECTION FOR MRI-NEGATIVE FOCAL CORTICAL DYSPLASIA TYPE II (A CASE REPORT).

Verification of focal cortical dysplasia (FCD) type IIa in pharmacoresistant epilepsy is a challenging diagnostic task due to the lack of specific structural changes on MRI. This requires an interdisciplinary approach and the use of functional neuroimaging methods.